tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IVA Stock Latest News

Inventiva S.A. Prepares for May 2025 General Meeting with Proxy Mailings
Company AnnouncementsInventiva S.A. Prepares for May 2025 General Meeting with Proxy Mailings
3d ago
6K
IVA
Inventiva Announces General Meeting to Discuss 2024 Financials and Strategic Initiatives
PremiumCompany Announcements
Inventiva Announces General Meeting to Discuss 2024 Financials and Strategic Initiatives
16d ago
6K
IVA
Inventiva’s Strategic Milestones and Promising Outlook Drive Buy Rating
PremiumRatings
Inventiva’s Strategic Milestones and Promising Outlook Drive Buy Rating
23d ago
IVA
Inventiva price target lowered to $9 from $12 at Guggenheim
PremiumThe Fly
Inventiva price target lowered to $9 from $12 at Guggenheim
23d ago
IVA
3 Best Stocks to Buy Now, 4/4/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 4/4/2025, According to Top Analysts
23d ago
IVA
XYZ
Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright
PremiumThe FlyInventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright
25d ago
IVA
Inventiva’s Strategic Advancements and Financial Strength Bolster Buy Rating
Premium
Ratings
Inventiva’s Strategic Advancements and Financial Strength Bolster Buy Rating
25d ago
IVA
Inventiva’s Strategic Advancements and Financial Positioning Drive Buy Rating
Premium
Ratings
Inventiva’s Strategic Advancements and Financial Positioning Drive Buy Rating
25d ago
IVA
Inventiva’s Promising Future: Buy Rating Backed by Phase III Milestone and Financial Stability
PremiumRatings
Inventiva’s Promising Future: Buy Rating Backed by Phase III Milestone and Financial Stability
25d ago
IVA
Inventiva Completes Enrollment for Phase 3 Trial of Lanifibranor
PremiumCompany Announcements
Inventiva Completes Enrollment for Phase 3 Trial of Lanifibranor
26d ago
6K
IVA
Inventiva’s Strategic Positioning and Clinical Progress Drive Buy Rating Amid Promising MASH Therapy Developments
PremiumRatings
Inventiva’s Strategic Positioning and Clinical Progress Drive Buy Rating Amid Promising MASH Therapy Developments
1M ago
IVA
Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates
PremiumCompany Announcements
Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates
1M ago
IVA
Promising Developments and Financial Outlook Propel Inventiva’s Phase III NATiV3 Trial Forward
PremiumRatingsPromising Developments and Financial Outlook Propel Inventiva’s Phase III NATiV3 Trial Forward
1M ago
IVA
Inventiva Reports 2024 Financial Results and Strategic Shift
Premium
Company Announcements
Inventiva Reports 2024 Financial Results and Strategic Shift
1M ago
6K
IVA
Inventiva publishes lanifibranor results in Biomedicine & Pharmacotherapy
Premium
The Fly
Inventiva publishes lanifibranor results in Biomedicine & Pharmacotherapy
2M ago
IVA
Inventiva initiated with a Buy at TD Cowen
PremiumThe Fly
Inventiva initiated with a Buy at TD Cowen
2M ago
IVA
Optimistic Buy Rating for Inventiva Driven by Lanifibranor’s Promising Phase 3 Prospects and Safety Profile
PremiumRatings
Optimistic Buy Rating for Inventiva Driven by Lanifibranor’s Promising Phase 3 Prospects and Safety Profile
2M ago
IVA
Inventiva and Hepalys Initiate Phase 1 Trial for Lanifibranor in Japan
PremiumCompany Announcements
Inventiva and Hepalys Initiate Phase 1 Trial for Lanifibranor in Japan
2M ago
6K
IVA
Inventiva & Japan’s Hepalys start lanifibranor clinical development program
PremiumThe Fly
Inventiva & Japan’s Hepalys start lanifibranor clinical development program
2M ago
IVA
Buy Rating for Inventiva: Strategic Focus on Lanifibranor and Strong Financial Outlook
PremiumRatingsBuy Rating for Inventiva: Strategic Focus on Lanifibranor and Strong Financial Outlook
2M ago
IVA
Inventiva Reports 2024 Financials and Strategic Shift to Focus on Lanifibranor
Premium
Company Announcements
Inventiva Reports 2024 Financials and Strategic Shift to Focus on Lanifibranor
3M ago
6K
IVA
Inventiva publishes lanifibranor trial results in Journal of Hepatology
Premium
The Fly
Inventiva publishes lanifibranor trial results in Journal of Hepatology
3M ago
IVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >